NDC 43826-044-01 - Guanfacine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43826-044
- Requested NDC
- 43826-044-01
- Package NDCs from labels
- 43826-044-01
- Manufacturer
- Bora Pharmaceutical Laboratories Inc. | TWi Pharmaceuticals, Inc. Zhongli Plant
- Effective date
- 2024-01-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Guanfacine Tablets, USP | Bora Pharmaceutical Laboratories Inc. | TWi Pharmaceuticals, Inc. Zhongli Plant | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Guanfacine | GUANFACINE | Proficient Rx LP | 09442806-db7b-49de-8ffc-e4cb83138349 | 2020-07-01 | Adverse reactions | PML56A160O |
| guanfacine | GUANFACINE | Actavis Pharma, Inc. | 3a171942-37af-430d-8b9d-bb678ca2be4b | 2020-01-31 | Warnings, Adverse reactions | PML56A160O |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.